CC
Christopher Causey

Christopher Causey insider trades: UNITED THERAPEUTICS (UTHR) stock sales

UNITED THERAPEUTICS Last trade Mar 30, 2026 188 Form 4 filings
$2.3M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
105
Open-market trades
since 2005
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christopher reports to the SEC

Open-market buys and sales

105 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 30, 2026UTHR↓ Sell$786K
Mar 4, 2026UTHR↓ Sell$10K
Feb 25, 2026UTHR↓ Sell$520K
Jan 6, 2026UTHR↓ Sell$510K
Jan 2, 2026UTHR↓ Sell$500K
Sep 24, 2025UTHR↓ Sell$440K
Sep 2, 2025UTHR↓ Sell$1.3M
Nov 1, 2024UTHR↓ Sell$192K
Aug 21, 2024UTHR↓ Sell$422K
Jun 18, 2024UTHR↓ Sell$913K
Jun 13, 2024UTHR↓ Sell$563K
May 15, 2024UTHR↓ Sell$546K
May 3, 2024UTHR↓ Sell$582K
Dec 15, 2023UTHR↓ Sell$102K
Dec 12, 2023UTHR↓ Sell$749K
Jan 3, 2023UTHR↓ Sell$276K
Nov 3, 2022UTHR↓ Sell$1.9M
Aug 23, 2022UTHR↓ Sell$787K
Jun 27, 2022UTHR↓ Sell$1.2M
May 26, 2022UTHR↓ Sell$1.1M
Aug 6, 2021UTHR↓ Sell$548K
Sep 10, 2018UTHR↓ Sell$96K
Sep 6, 2018UTHR↓ Sell$96K
Dec 7, 2017UTHR↓ Sell$78K
Nov 6, 2017UTHR↓ Sell$71K
Oct 5, 2017UTHR↓ Sell$71K
Sep 7, 2017UTHR↓ Sell10b5-1$78K
Aug 3, 2017UTHR↓ Sell$74K
Jul 6, 2017UTHR↓ Sell10b5-1$78K
Aug 6, 2015UTHR↓ Sell$250K
Jul 2, 2015UTHR↓ Sell$258K
Jun 4, 2015UTHR↓ Sell$272K
May 7, 2015UTHR↓ Sell$252K
Apr 2, 2015UTHR↓ Sell$523K
Mar 5, 2015UTHR↓ Sell$474K
Feb 5, 2015UTHR↓ Sell$421K
Jan 2, 2015UTHR↓ Sell$388K
Dec 19, 2014UTHR↓ Sell$197K
Dec 4, 2014UTHR↓ Sell$197K
Nov 20, 2014UTHR↓ Sell$191K
Nov 6, 2014UTHR↓ Sell$184K
Oct 2, 2014UTHR↓ Sell$196K
Sep 4, 2014UTHR↓ Sell$170K
Aug 15, 2014UTHR↓ Sell$137K
Jul 3, 2014UTHR↓ Sell$137K
Jun 5, 2014UTHR↓ Sell$145K
May 1, 2014UTHR↓ Sell$149K
Apr 3, 2014UTHR↓ Sell$144K
Mar 20, 2014UTHR↓ Sell$144K
Feb 6, 2014UTHR↓ Sell$146K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other UTHR insiders

Open-market trades in the last 12 months

About Christopher Causey's insider trades

Christopher Causey is an insider at UNITED THERAPEUTICS (UTHR). Since May 6, 2005, Christopher has reported no open-market purchases and 105 sales worth $27.0M on SEC Form 4. In the last 12 months: 5 sales ($2.3M).

20 sales (8% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (154 filings), shares returned to the company (54 filings), grants and awards (19 filings), gifts (10 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UTHR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.